Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.

Anne Hege AamodtEinar August HøgestølTrine Haug PopperudJan Cato HolterAnne Ma Dyrhol-RiiseKristian TonbyBirgitte StiksrudElse Quist-PaulsenTone BergeAndreas Barratt-DuePål AukrustLars HeggelundKaj BlennowHenrik ZetterbergHanne Flinstad Harbo

Published in: Journal of neurology (2021)

Increased concentrations of NfL and GFAp in COVID-19 patients on admission may indicate increased mortality risk. Measurement of blood biomarkers for nervous system injury can be useful to detect and monitor CNS injury in COVID-19.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
emergency department
cerebrospinal fluid
human health
climate change